ExLibris header image
SFX Logo
Title: Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line-Treatment of Patients with Follicular, Indolent and Mantle Cell Lymphomas: Results of a Randomized Phase III Study of the Study Group Indolent Lymphomas (StiL)
Source:

Blood [0006-4971] Rummel, Mathias yr:2008


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Tedeschi, A. "FINAL RESULTS OF THE PHASE II MULTICENTER ITALIAN STUDY OF IMMUNOCHEMOTHERAPY WITH FLUDARABINE, CYCLOPHOSPHAMIDE AND RITUXIMAB (FCR) FOR SYMPTOMATIC WALDENSTROM'S MACROGLOBULINEMIA." Haematologica 94 (2009): 164-164. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced